WO2012061536A3 - Methods for treating hair loss disorders - Google Patents
Methods for treating hair loss disorders Download PDFInfo
- Publication number
- WO2012061536A3 WO2012061536A3 PCT/US2011/059027 US2011059027W WO2012061536A3 WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3 US 2011059027 W US2011059027 W US 2011059027W WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- hair loss
- treating hair
- loss disorders
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
The invention provides for methods for treating a hair loss disorder in a subject by administering a NKG2D inhibitor, IL-15 inhibitor, or a combination thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40951410P | 2010-11-02 | 2010-11-02 | |
US61/409,514 | 2010-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012061536A2 WO2012061536A2 (en) | 2012-05-10 |
WO2012061536A3 true WO2012061536A3 (en) | 2014-04-10 |
Family
ID=46025095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/059027 WO2012061536A2 (en) | 2010-11-02 | 2011-11-02 | Methods for treating hair loss disorders |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012061536A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993097A (en) * | 2012-11-09 | 2013-03-27 | 贵州大学 | Pyrazole amide compound and application thereof |
KR20220020879A (en) | 2019-06-12 | 2022-02-21 | 에스크진 파마, 아이엔씨. | New IL-15 prodrugs and how to use them |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080069791A1 (en) * | 2003-12-29 | 2008-03-20 | Universitaetsklinikum Muenster | Means for stimulation and activation of hair growth by il-15 |
-
2011
- 2011-11-02 WO PCT/US2011/059027 patent/WO2012061536A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080069791A1 (en) * | 2003-12-29 | 2008-03-20 | Universitaetsklinikum Muenster | Means for stimulation and activation of hair growth by il-15 |
Also Published As
Publication number | Publication date |
---|---|
WO2012061536A2 (en) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012061537A3 (en) | Methods for treating hair loss disorders | |
WO2012006538A8 (en) | Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereof | |
WO2014042433A3 (en) | Compounds and compositions for modulating adenosine a3 receptor activity | |
PT2649242E (en) | Method for building structures, particularly passages under operating railways or the like. | |
WO2014035140A3 (en) | Compounds and compositions for modulating histone methyltransferase activity | |
HK1193091A1 (en) | Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3- en-2-ones for therapy 3-(-3-)-88--4--1-[45]-3--2- | |
WO2011142858A3 (en) | Chlorotoxin variants, conjugates, and methods for their use | |
WO2012166626A8 (en) | Reagents and methods for treating dental disease | |
WO2012103393A3 (en) | Controlling mealybugs | |
TN2010000096A1 (en) | Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors | |
WO2011133504A3 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
WO2011075636A3 (en) | Wise binding agents and epitopes | |
WO2012058219A3 (en) | Deuterium enriched rasagiline | |
HK1193100A1 (en) | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament -3--[310]-3-- | |
EP2729464B8 (en) | Cyclopropyl-fused-1,3-thiazepines as bace 1 and/or bace 2 inhibitors | |
WO2011130347A3 (en) | Methods for enhancing axonal regeneration | |
WO2013023151A3 (en) | Compositions and methods for treating celiac sprue disease | |
WO2011083483A3 (en) | Method for treatment of inflammatory disease and disorder | |
WO2012064743A3 (en) | Methods for improving heart function | |
WO2013016280A3 (en) | Compositions and methods for selecting aptamers | |
WO2012154533A3 (en) | Controlling planthoppers | |
WO2011110624A3 (en) | β-HYDROXYALKYLAMIDES, METHOD FOR THEIR PRODUCTION AND USE THEREOF | |
WO2011133893A3 (en) | Cyanide antidotes | |
WO2012080466A3 (en) | Ingenols for treating seborrheic keratosis | |
WO2012061536A3 (en) | Methods for treating hair loss disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11838770 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11838770 Country of ref document: EP Kind code of ref document: A2 |